Lista de obras - Ming Shi - Dominio Público Uruguay

A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.

artículo científico

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma

scientific article published on 01 May 2009

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy

artículo científico publicado en 2018

An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma.

artículo científico publicado en 2012

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

artículo científico publicado en 2011

CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis

scientific article published on 11 July 2018

Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma.

artículo científico publicado en 2011

Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma

artículo científico publicado en 2013

Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma

artículo científico publicado en 2006

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro

scientific article published on 18 November 2021

Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.

artículo científico publicado en 2012

Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.

artículo científico publicado en 2013

Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

artículo científico publicado en 2015

Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis

article

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.

artículo científico publicado en 2008

Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study.

artículo científico publicado en 2013

LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma

artículo científico publicado en 2010

Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin

scientific article published on 17 March 2004

Morphologic classification of microvessels in hepatocellular carcinoma is associated with the prognosis after resection.

artículo científico publicado en 2011

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

artículo científico publicado en 2007

Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis

artículo científico publicado en 2018

Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

artículo científico publicado en 2019

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study

artículo científico publicado en 2012

Response to Dr Chan et al

artículo científico publicado en 2013

Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection

artículo científico publicado en 2013

Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial

artículo científico publicado en 2012

Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

artículo científico publicado en 2010

Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study

scientific article published on 14 September 2010

[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]

scientific article published on 01 January 2008

[Correlation of preoperative neutrophil-to-lymphocyte ratio to prognosis of young patients with hepatocellular carcinoma]

artículo científico publicado en 2009

[Effects of cetuximab combined erlotinib on proliferation of human hepatocellular carcinoma cell lines HepG2 and Bel-7402]

artículo científico publicado en 2008

[Efficacy of pulmonary resection for primary hepatocellular carcinoma patients with pulmonary metastasis]

artículo científico publicado en 2008

[Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy]

scientific article published on 01 July 2005

[Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma]

scientific article published on 01 April 2006

[Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma]

artículo científico publicado en 2006

[Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma]

artículo científico publicado en 2006

[Expression of CXCR3 in hepatocellular carcinoma]

artículo científico publicado en 2006

[Influence of surgical resection margin in hepatectomy on survival of patients with hepatocellular carcinoma]

scientific article published on 01 January 2006

[Micrometastasis distribution in liver tissue surrounding hepatocellular carcinoma].

artículo científico publicado en 2002

[Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma]

artículo científico publicado en 2006

[Prophylaxis and clinical treatment for surgical margin recurrence of small primary hepatocellular carcinoma]

artículo científico publicado en 2005

[The value of TissueLink hemostatic sealer in hepatectomy for hepatocellular carcinoma]

scientific article published on 01 November 2006

Lista de obras de Ming Shi

A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy

An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma.

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis

Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma.

Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma

Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro

Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis.

Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.

Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.

Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study.

LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma

Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin

Morphologic classification of microvessels in hepatocellular carcinoma is associated with the prognosis after resection.

Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.

Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis

Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study

Response to Dr Chan et al

Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection

Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial

Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study

[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]

[Correlation of preoperative neutrophil-to-lymphocyte ratio to prognosis of young patients with hepatocellular carcinoma]

[Effects of cetuximab combined erlotinib on proliferation of human hepatocellular carcinoma cell lines HepG2 and Bel-7402]

[Efficacy of pulmonary resection for primary hepatocellular carcinoma patients with pulmonary metastasis]

[Evaluation of new TNM staging system for hepatocellular carcinoma after hepatectomy]

[Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma]

[Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma]

[Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma]

[Expression of CXCR3 in hepatocellular carcinoma]

[Influence of surgical resection margin in hepatectomy on survival of patients with hepatocellular carcinoma]

[Micrometastasis distribution in liver tissue surrounding hepatocellular carcinoma].

[Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma]

[Prophylaxis and clinical treatment for surgical margin recurrence of small primary hepatocellular carcinoma]

[The value of TissueLink hemostatic sealer in hepatectomy for hepatocellular carcinoma]